Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)
Dan H. Barouch(Beth Israel Deaconess Medical Center), Ludo Lavreys(Janssen (Belgium)), Glenda Gray(South African Medical Research Council), Caroline Borremans(Janssen (Belgium)), Lauren Peter(Beth Israel Deaconess Medical Center), Kundai Chinyenze(International AIDS Vaccine Initiative), Juliet Mpendo(Uganda Virus Research Institute), Bette Korber(Los Alamos National Laboratory), Thomas Campbell(University of Colorado Denver), Etienne Karita(University of Namur), Lorenz Scheppler(Janssen (Belgium)), Erica N. Borducchi(Beth Israel Deaconess Medical Center), Georgia D. Tomaras(Duke University), Jerald Sadoff(University of Maryland, Baltimore), Kathryn E. Stephenson(Beth Israel Deaconess Medical Center), Nelson L. Michael(Walter Reed Army Institute of Research), Roland Zahn(Human Vaccines Project Europe), Stephan Bart(Optimal Solutions (United States)), Edith Swann(National Institutes of Health), Nicole Frahm(Fred Hutch Cancer Center), Frances Priddy(International AIDS Vaccine Initiative), Jessica Vreugdenhil(Janssen (Netherlands)), Fatima Laher(Norwegian Womens Public Health Association), Punnee Pitisuttithum(Mahidol University), Mo Weijtens(Janssen (Netherlands)), Galit Alter(Ragon Institute of MGH, MIT and Harvard), David Jetton(Beth Israel Deaconess Medical Center), Daniëlle van Manen(Janssen (Netherlands)), Abishek Chandrashekar(Beth Israel Deaconess Medical Center), Hannah Kibuuka(Makerere University Walter Reed Project), Daniel J Stieh(Janssen (Netherlands)), Sorachai Nitayapan(Armed Forces Research Institute of Medical Science), Erica Lazarus(Norwegian Womens Public Health Association), Merlin L. Robb(University of Maryland, Baltimore), Raphaele Roten(Janssen (Belgium)), Gregg Lucksinger, Katleen Callewaert(Janssen (Belgium)), Frank Wegmann(Janssen (Netherlands)), M. Juliana McElrath(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Lindsey R. Baden(Brigham and Women's Hospital), Joseph P. Nkolola(Beth Israel Deaconess Medical Center), Julia Hütter(National Institutes of Health), Wenjun Li(Tianjin Medical University), Jennifer Johnson(Brigham and Women's Hospital), Robert Feldman, Frank Tomaka(Janssen (United States)), David C. Montefiori(University of Sheffield), Karin Feddes-de Boer(Janssen (Netherlands)), Nigel Garrett(Centre for the AIDS Programme of Research in South Africa)
Cited by 342
Related Papers
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
|Cell|2020|4.5k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Gender-based violence, relationship power, and risk of HIV infection in women attending antenatal clinics in South Africa
|The Lancet|2004|1.3k
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
|Nature|2002|1.2k
DNA vaccine protection against SARS-CoV-2 in rhesus macaques
|Science|2020|1.1k